Mon, January 9, 2023
Sun, January 8, 2023
Fri, January 6, 2023
Thu, January 5, 2023
Wed, January 4, 2023
Tue, January 3, 2023
Fri, December 30, 2022

Matthew O"Brien Maintained (ZBH) at Hold with Increased Target to $130 on, Jan 5th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-130-on-jan-5th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew O"Brien of Piper Sandler, Maintained "Zimmer Biomet Holdings, Inc." (ZBH) at Hold with Increased Target from $120 to $130 on, Jan 5th, 2023.

Matthew has made no other calls on ZBH in the last 4 months.

There are 7 other peers that have a rating on ZBH. Out of the 7 peers that are also analyzing ZBH, 5 agree with Matthew"s Rating of Hold. Following are those relevant analyst calls for the last 4 months;

Vijay Kumar of "Evercore ISI Group" Downgraded from Buy to Hold and Held Target at $130 on, Tuesday, January 3rd, 2023
Richard Newitter of "Truist Securities" Maintained at Hold with Increased Target to $135 on, Tuesday, December 20th, 2022
Joanne Wuensch of "Citigroup" Maintained at Hold with Increased Target to $130 on, Monday, December 12th, 2022
Larry Biegelsen of "Wells Fargo" Upgraded from Sell to Hold and Increased Target to $124 on, Wednesday, November 23rd, 2022
Shagun Singh of "RBC Capital" Maintained at Hold with Decreased Target to $125 on, Thursday, November 3rd, 2022

These are the ratings of the 2 analyists that currently disagree with Matthew;

Matt Miksic of "Barclays" Initiated at Sell and Held Target at $104 on, Tuesday, October 18th, 2022
Matthew Taylor of "Jefferies" Initiated at Sell and Held Target at $95 on, Wednesday, October 12th, 2022


Publication Contributing Sources